老年人的活力:一项最新科学审查
Ilana I Logvinov1, Victoria Loerzel1
1University of Central Florida, Dr. Philips Nursing Pavillon, 6825 Lake Nona Blvd, Orlando, FL 32827, USA.
Archives of gerontology and geriatrics
|November 15, 2025
概括
老年人的活力是复杂的,受到身体,情绪和社会因素的影响. 通过活动和社会参与来促进福祉可以增强活力,但慢性疾病带来了挑战.
科学领域:
- 老年学是一门学科.
- 护理科学 护理科学
- 生物心理社会健康 生物心理社会健康
背景情况:
- 活力是一种公认的多维生物生理状态.
- 像生活质量这样的现有构造不能完全捕捉生命力的复杂性.
- 关于如何定义或测量活力,没有共识.
研究的目的:
- 审查关于老年人活力的科学现状.
- 检查如何定义,评估和影响活力.
- 发现当前研究和实践中的差距.
主要方法:
- 35项研究研究的系统审查.
- 综合了有关生命力定义,评估和影响因素的发现.
- 分析测量工具及其领域覆盖范围.
主要成果:
- 在活力测量工具中存在显著的变化.
- 低强度的体力活动,心理健康,社会参与和良好的身体健康都能增强活力.
- 慢性疾病,孤立和心理健康挑战会降低活力.
结论:
- 需要一个统一的生命力的概念框架.
- 需要全面的评估工具,反映老年人的观点.
- 以人为中心的干预措施可以促进健康的衰老和活力.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221


